SCHEMBL755028

SCHEMBL755028

O=P(Cc1ccc(CP(=O)(c2ccccc2)c2ccccc2)cc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.68
CYP2C19 P33261 1/20 0.68
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
ALDH1A1 P00352 5/20 0.54
GAA P10253 3/20 0.54
NPSR1 Q6W5P4 3/20 0.54
HTT P42858 2/20 0.54
MAPT P10636 2/20 0.54
ALPG P10696 1/20 0.54
ALOX12 P18054 1/20 0.54
NPY1R P25929 1/20 0.54
NPY2R P49146 1/20 0.54
USP2 O75604 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.50
LMNA P02545 1/20 0.48
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL518265 0.95 CYP3A4 (0.68) CYP3A4CYP2C19MEN1KMT2AALDH1A1
SCHEMBL16413936 0.93 CYP3A4 (0.61) CYP3A4CYP2C19MEN1KMT2AALDH1A1
SCHEMBL29119882 0.91 CYP3A4 (0.59) CYP3A4CYP2C19MEN1KMT2AALDH1A1
SCHEMBL13066249 0.91 CYP3A4 (0.59) CYP3A4CYP2C19MEN1KMT2AALDH1A1
SCHEMBL29119917 0.89 CYP3A4 (0.58) CYP3A4CYP2C19MEN1KMT2AALDH1A1
SCHEMBL18486517 0.89 CYP3A4 (0.58) CYP3A4CYP2C19MEN1KMT2AALDH1A1
SCHEMBL29119860 0.89 CYP3A4 (0.58) CYP3A4CYP2C19MEN1KMT2AALDH1A1
SCHEMBL20462898 0.89 CYP3A4 (0.58) CYP3A4CYP2C19MEN1KMT2AALDH1A1
SCHEMBL10910019 0.89 CYP3A4 (0.58) CYP3A4CYP2C19MEN1KMT2AALDH1A1
SCHEMBL10297869 0.88 CYP3A4 (0.56) CYP3A4CYP2C19MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174623-A1 Build UP Film Curable Compositions AGC Multi Material America, Inc. 2024-05-30 US disclosed
US-20240174802-A1 Build UP Film Curable Compositions AGC MULTI MAT AMERICA INC (US) 2024-05-30 US disclosed
CN-118048008-A Curable composition for build-up film AGC多材料美国有限公司 2024-05-17 CN disclosed
US-11760876-B2 Resin composition and article made therefrom Elite Material Co., Ltd. (TW) 2023-09-19 US disclosed
US-11760876-B2 Resin composition and article made therefrom Elite Material Co., Ltd. (TW) 2023-09-19 US disclosed
US-20230250282-A1 RESIN COMPOSITION, PREPREG, FILM WITH RESIN, METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2023-08-10 US disclosed
US-20230250282-A1 RESIN COMPOSITION, PREPREG, FILM WITH RESIN, METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2023-08-10 US disclosed
US-20220169852-A1 RESIN COMPOSITION, PREPREG, LAMINATE, MULTILAYER PRINTED WIRING BOARD, AND SEMICONDUCTOR PACKAGE RESONAC CORPORATION (JP) 2022-06-02 US disclosed
EP-3950841-A1 RESIN COMPOSITION, PREPREG, LAMINATE, MULTILAYER PRINTED WIRING BOARD, AND SEMICONDUCTOR PACKAGE Showa Denko Materials Co., Ltd. (JP) 2022-02-09 EP disclosed
US-11118055-B2 Phosphorus-containing resin composition and article made therefrom Elite Material Co., Ltd. (TW) 2021-09-14 US disclosed
EP-2430090-B1 PHOSPHORUS-CONTAINING FLAME RETARDANTS FOR GLASS-FILLED POLYAMIDE RESINS CHEMTURA CORP (US) 2013-01-09 EP disclosed
EP-2430090-B1 PHOSPHORUS-CONTAINING FLAME RETARDANTS FOR GLASS-FILLED POLYAMIDE RESINS CHEMTURA CORP (US) 2013-01-09 EP disclosed
US-20120172501-A1 PHOSPHORUS-CONTAINING FLAME RETARDANTS LANXESS SOLUTIONS US INC. 2012-07-05 US disclosed
US-20120172501-A1 PHOSPHORUS-CONTAINING FLAME RETARDANTS LANXESS SOLUTIONS US INC. 2012-07-05 US disclosed
US-20120172501-A1 PHOSPHORUS-CONTAINING FLAME RETARDANTS LANXESS SOLUTIONS US INC. 2012-07-05 US disclosed
EP-2430090-A1 PHOSPHORUS-CONTAINING FLAME RETARDANTS Chemtura Corporation (US) 2012-03-21 EP disclosed
WO-2010132332-A1 PHOSPHORUS-CONTAINING FLAME RETARDANTS CHEMTURA CORPORATION (US) 2010-11-18 WO disclosed
WO-2010132332-A1 PHOSPHORUS-CONTAINING FLAME RETARDANTS CHEMTURA CORPORATION (US) 2010-11-18 WO disclosed
US-20100292376-A1 PHOSPHORUS-CONTAINING FLAME RETARDANTS CHEMTURA CORPORATION (US) 2010-11-18 US disclosed
US-20100292376-A1 PHOSPHORUS-CONTAINING FLAME RETARDANTS CHEMTURA CORPORATION (US) 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174623-A1 Build UP Film Curable Compositions CBX7, CBX4, CBX2 CYP3A4 1660/4885CYP2C19 1686/4885MEN1 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.